53067-82-6

Basic information

• Product Name: 11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE
• Synonyms: 11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE;(8S,9S,10R,11R,13S,14S)-13-ethyl-11-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione
• CAS NO: 53067-82-6
• Molecular Formula: C₁₉H₂₆O₃
• Molecular Weight: 302.41
• Mol File: 53067-82-6.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 489.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.19
• Storage Temp.: 2-8°C
• PKA: 14.48±0.40(Predicted)
• CAS DataBase Reference: 11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE(53067-82-6)
• EPA Substance Registry System: 11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE(53067-82-6)

Safety Data

• Hazardous Substances Data: 53067-82-6(Hazardous Substances Data)

Usage

General Description

11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE, also known as mestanolone, is a synthetic androgenic steroid that is derived from the male sex hormone testosterone. It is commonly used in the medical field for its androgenic and anabolic effects, and is also sometimes used in sports and bodybuilding as a performance-enhancing drug. Mestanolone is known to increase muscle mass and strength, as well as promote fat loss, making it a popular choice for athletes and bodybuilders looking to improve their physical performance. However, it is important to note that the use of mestanolone can have serious side effects, including liver damage, cardiovascular issues, and hormonal imbalances. Therefore, it is crucial that this substance is used under the guidance of a medical professional and with caution.

Upstream product

• 19882-75-8 13-Ethyl-3-methoxygona-1,3,5⁽¹⁰⁾,9⁽¹¹⁾-tetraen-17-one 
• 21800-83-9 13β-ethyl-gon-4-en-3,17-dione 

Downstream Products

• 184778-59-4 13β-ethyl-11α-hydroxygon-5-ene-3,17-dione-3,17-diethylene ketal 
• 100071-90-7 18-methyl-estra-4-en-3,11,17-trione 
• 1574323-08-2 C₂₂H₃₂O₃ 
• 1574323-07-1 C₂₁H₃₀O₄ 
• 168131-50-8 18a-methylestr-5-ene-3,11,17-trione cyclic 3-(1,2-ethanediyl acetal) 
• 100071-89-4 18a-homoestr-5-ene-3,11,17-trione cyclic 3,17-bis(1,2-ethanediyl acetal) 
• 56294-43-0 13-ethyl-11-methylenegon-5-ene-3,17-dione cyclic bis(1,2-ethanediyl acetal) 
• 196716-44-6 D-13β-Ethyl-11β-hydroxy-11α-methylgon-5-ene-3,11-dione-3,17-diethylene ketal 
• 196716-45-7 D-13β-Ethyl-3,3-ethylenedithio-11-methylenegon-4-ene-17α-ol 
• 196716-46-8 D-13β-Ethyl-11-methylenegon-4-en-17α-ol 
• 196716-43-5 13β-ethyl-gona-5-ene-3,11,17-trione-3,17-diethylene ketal 
• 54024-21-4 11-methylene-18a-homo-estr-4-en-17-one 
• 54024-18-9 13-ethyl-11-methylenegon-4-ene-3,17-dione cyclic 3-(1,2-ethanediyl dithioacetal) 
• 54024-17-8 13β-ethyl-11-methylenegon-4-en-3,17-dione 

Relevant articles and documents

Intermediate for synthesis of desogestrel and preparation method thereof

The invention relates to a steroid compound and application of the same to preparation of a desogestrel intermediate, i.e., 13-ethylsterane-3,11,17-trione. The novel compound is prepared through oxidation, transposition, hydroboration-oxidation, ketalization and a lithium-ammonia reaction of starting materials; and then 13-ethylsterane-3,11,17-trione is prepared by using the compound, and the preparation process is simple, easily practicable, environment-friendly, high in yield, and suitable for industrial production.